BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10580184)

  • 1. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
    Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
    Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
    Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
    Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
    Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
    Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of renal dysfunction in patients with stable angina pectoris.
    Almquist T; Forslund L; Rehnqvist N; Hjemdahl P
    J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
    Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
    Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
    Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris.
    Held C; Björkander I; Forslund L; Rehnqvist N; Hjemdahl P
    Diabet Med; 2005 Oct; 22(10):1326-33. PubMed ID: 16176191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Forslund L; Björkander I; Angelin B; Wiman B
    J Intern Med; 1997 Jan; 241(1):59-69. PubMed ID: 9042095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
    Held C; Hjemdahl P; Eriksson SV; Björkander I; Forslund L; Rehnqvist N
    Eur Heart J; 2001 Jan; 22(1):62-72. PubMed ID: 11133211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.
    Forslund L; Björkander I; Ericson M; Held C; Kahan T; Rehnqvist N; Hjemdahl P
    Heart; 2002 May; 87(5):415-22. PubMed ID: 11997407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.
    Wallén NH; Held C; Rehnqvist N; Hjemdahl P
    Am J Cardiol; 1995 Jan; 75(1):1-6. PubMed ID: 7801853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
    Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
    Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists and primary prevention of coronary disease].
    Rehnqvist N
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():13-6. PubMed ID: 7503620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
    Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls.
    Billing E; Hjemdahl P; Rehnqvist N
    Eur Heart J; 1997 Jun; 18(6):911-8. PubMed ID: 9183581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
    Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
    Haverkate F; Thompson SG; van de Loo JC
    Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.